The immune response to the capsular polysaccharide of Neisseria meningitidis group B

Zentralblatt fur Bakteriologie

Volumn 285, Issue 3, 1997, Pages 331-340

  Diaz Romero, J ^a   Outschoorn, I M ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8244225185     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(97)80001-1     Document Type: Article

References (62)

1. Adlam, C., J. M. Knights, A. Mugridge, J. M. Williams, and J. C. Lindon: Production of colominic acid by Pasteurella baemolytica serotype A2 organisms. FEMS Microbiol. Lett. 42 (1987) 23-25
2. Allen, P. Z., M. Glode, R. Schneerson, and J. B. Robbins: Identification of immunoglobulin heavy-chain isotypes of specific antibodies of horse 46 group B meningococcal antiserum. J. Clin. Microbiol. 15 (1982) 324-329
3. Avrameas, S. and T. Ternynck: The natural autoantibodies system: between hypotheses and facts. Mol. Immunol. 30 (1993) 1133-1142
4. Azmi, F. H., A. H. Lucas, H. V. Raff, and D. M. Granoff: Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Infect. Immun. 62 (1994) 1776-1786
5. Azmi, F. H., A. H. Lucas, H. L. Spiegelberg, and D. M. Granoff: Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain. Infect. Immun. 63 (1995) 1906-1913
6. Barbeau, D., J. J. Liang, Y. Robitaille, R. Quirion, and L. K. Srivastava: Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc. Natl. Acad. Sci. USA 92 (1995) 2785-2789
7. Bartoloni, A., F. Norelli, C. Ceccarini, R. Rappuoli, and P. Constantino: Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipidic acid dihydrazide. Vaccine 13 (1995) 463-470
8. Brisson, J. R., H. Baumann, A. Imberty, S. Perez, and H. J. Jennings: Helical epitope of the group B meningococcal α(2-8)-linked sialic acid polysaccharide. Biochemistry 31 (1992) 4996-5004
9. Cartwright, K. A., J. M. Stuart, D. M. Jones, and N. D. Noah: The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol. Infect. 99 (1987) 591-601
10. De la Fuente, M. A., C. Egile, A. Pereira, et al.: Characterization of a monoclonal IgMK (IgMGAS) anti-Gd cold agglutinin (CA). Its coexistence with a monoclonal IgG3K (IgGGAS) without CA activity that might be clonally related to IgMGAS. Blood 83 (1994) 1310-1322
11. Densen, P.: Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae. Clin. Microbiol. Rev. 2 Suppl. (1989) S11-S17
12. Devi, J. N., J. B. Robbins, and R. Schneerson: Conjugate vaccine for induction of poly [(2-8)-α-N-acetylneuraminic acid] antibodies. NIPH Ann. 14 (1991) 243-245
13. Devi, S. J., J. B. Robbins, and R. Schneerson: Antibodies to poly[(2-8)-α-N-acetyl-neuraminic acid] and poly [(2-9)-α-N-acetyl neuraminic acid] are elicited by immunizing mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and Escherichia coli K1. Proc. Natl. Acad. Sci. USA 88 (1991) 7175-7179
14. Devi, S. J., R. Schneerson, W. Egan, W. F. Vann, J. B. Robbins, and J. Shiloach: Identity between polysaccharide antigens of Moraxella non-liquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated). Infect. Immun. 59 (1991) 732-736
15. Diaz Romero, J. and I. Outschoorn: Selective biotinylation of Neisseria meningitidis group B capsular polysaccharide and application in an improved ELISA for the detection of specific antibodies. J. Immunol. Methods 160 (1993) 35-47
16. Diaz Romero, J. and I. Outschoorn: Detection of antibodies to Neisseria meningitidis serogroup B capsular polysaccharide by a liquid-phase ELISA. In: Polysialic acid: from microbes to man. Birkhäuser Verlag, Basel (1993) 39-48
17. Diaz Romero, J. and I. M. Outschoorn: Current status of meningococcal group B vaccine candidates: capsular or noncapsular? Clin. Microbiol. Rev. 7 (1994) 559-575
18. Diaz Romero, J. and I. M. Outschoorn: Use of an ELISA with biotinylated meningococcal polysaccharides to study the immune response to the capsular polysaccharide of Neisseria meningitidis group B in different animal species. Submitted (1995)
19. Evans, S. V., B. W. Sigurskjold, H. J. Jennings, et al.: Evidence for the extended helical nature of polysaccharide epitopes - the 2.8 angstrom resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for α-(2-8)-polysialic acid. Biochemistry 34 (1995) 6737-6744
20. Figueroa, J. E. and P. Densen: Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4 (1991) 359-395
21. Frasch, C. E. and M. S. Peppler: Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens. Infect. Immun. 37 (1982) 271-280
22. Frosch, M., I. Gorgen, G. J. Boulnois, K. N. Timmis, and D. Bitter Suermann: NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. Proc. Natl. Acad. Sci. USA 82 (1985) 1194-1198
23. Glode, M. P., E. B. Lewin, A. Sutton, C. T. Le, E. C. Gotschlich, and J. B. Robbins: Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers. J. Infect. Dis. 139 (1979) 52-59
24. Hammerschmidt, A., A. Unkmeier, J. P. M. van Putten, and M. Frosch: Influence of capsular polysaccharide and LOS sialylation on serum resistance and invasive properties in meningococci serogroups A, B and C. In: Proceedings of the Ninth Internacional Pathogenic Neisseria Conference (1994) 36-37
25. Hurpin, C. M., E. D. Carosella, and P. A. Cazenave: Bactericidal activity of 2 IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide. Hybridoma 11 (1992) 677-687
26. Jarvis, G. A. and N. A. Vedros: Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55 (1987) 174-180
27. Jennings, H. J.: The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Contrib. Microbiol. Immunol. 10 (1989) 151-165
28. Jennings, H. J., A. Gamian, and F. E. Ashton: N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis. J. Exp. Med. 165 (1987) 1207-1211
29. Jennings, H. J., A. Gamian, F. Michon, and F. E. Ashton: Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1. J. Immunol. 142 (1989) 3585-3591
30. Jennings, H. J. and C. Lugowski: Immunochemistry of groups A, B and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127 (1981) 1011-1018
31. Jennings, H. J., R. Roy, and A. Gamian: Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B poly-saccharide-tetanus toxoid conjugate vaccine. J. Immunol. 137 (1986) 1708-1713
32. Jerne, N. K.: Toward a network theory of the immune system. Ann. Immunol. 125 (1974) 373-389
33. Kabat, E. A., K. G. Nickerson, J. Liao, et al.: A human monoclonal macroglobulin with specificity for alpha(2-8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which cross-reacts with polynucleotides and with denatured DNA. J. Exp. Med. 164 (1986) 642-654
34. Kasper, D. L., J. L. Winkelhake, B. L. Brandt, and M. S. Artenstein: Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J. Infect. Dis. 127 (1973) 378-387
35. Kasper, D. L., J. L. Winkelhake, W. D. Zollinger, B. L. Brandt, and M. S. Artenstein: Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1 (L): NM and group B Neisseria meningitidis. J. Immunol. 110 (1973) 262-268
36. Kim, K. S., H. Itabashi, P. Gemski, J. Sadoff, R. L. Warren, and A. S. Cross: The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J. Clin. Invest. 90 (1992) 897-905
37. Kirschfink, M., H. Fritze, and D. Roelcke: Complement activation by cold agglutinins. Vox Sang 63 (1992) 220-226
38. Komminoth, P., J. Roth, S. Schroder, P. Saremaslani, and P. U. Heitz: Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas - implications for the differential diagnosis of adrenal gland tumors. Laboratory Investigation 72 (1995) 424-431
39. Lifely, M. R., C. Moreno, and J. C. Lindon: An integrated molecular and immunological approach towards a meningococcal group B vaccine. Vaccine 5 (1987) 11-25
40. Lifely, M. R., S. C. Roberts, W. M. Shepherd, et al.: Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins. Vaccine 9 (1991) 60-66
41. Lifely, M. R. and Z. Wang: Immune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane proteins. Infect. Immun. 56 (1988) 3221-3227
42. Liu, T. Y., E. C. Gotschlich, W. Egan, and J. B. Robbins: Sialic acid-containing polysaccharides of Neisseria meningitidis and Escherichia coli strain Bos-12: structure and immunology. J. Infect. Dis. 136 (Suppl.) (1977) S71-S77
43. Mandrell, R. E., F. H. Azmi, and D. M. Granoff: Complement-mediated bactericidal activity of human antibodies to poly α2-8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J. Infect. Dis. 172 (1995) 1279-1289
44. Mandrell, R. E. and W. D. Zollinger: Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. J. Immunol. 129 (1982) 2172-2178
45. Manzi, A. E., H. H. Higa, S. Diaz, and A. Varki: Intramolecular self-cleavage of polysialic acid. Journal of Biological Chemistry 269 (1994) 23617-23624
46. Masson, L., B. E. Holbein, and F. E. Ashton: Virulence linked to polysaccharide production in serogroup B Neisseria meningitidis. FEMS Microbiol. Lett. 13 (1982) 187-190
47. Moreno, C., M. R. Lifely, and J. Esdaile: Immunity of protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide. Infect. Immun. 47 (1985) 527-533
48. Nato, F., J. C. Mazie, J. M. Fournier, et al.: Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents. J. Clin. Microbiol. 29 (1991) 1447-1452
49. Nedelec, J., J. Boucraut, J. M. Gamier, D. Bernard, and G. Rougon: Evidence for autoimmune antibodies directed against embryonic neural cells adhesion molecules (N-CAM) in patients with group-B meningitis. J. Neuroimmunol. 29 (1990) 45-56
50. Platt, M. W., N. J. Correa, and C. Mold: Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway. Can. J. Microbiol. 40 (1994) 99-105
51. Pruzanski, W. and K. H. Shumak: Biologic activity of cold-reacting autoantibodies (First of two parts). N. Engl. J. Med. 297 (1977) 538-542
52. Rutishauser, U., A. Acheson, A. K. Hall, D. M. Mann, and J. Sunshine: The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 240 (1988) 53-57
53. Saukkonen, K., M. Haltia, M. Frosch, D. Bitter Suermann, and M. Leinonen: Antibodies to the capsular polysaccharide of Neisseria meningitidis group B or E. colt K1 bind to the brains of infant rats in vitro but not in vivo. Microb. Pathog. 1 (1986) 101-105
54. Shoenfeld, Y., A. Beresovski, D. Zharhary, et al.: Natural autoantibodies in sera of patients with Gaucher's disease. J. Clin. Immunol. 15 (1995) 363-372
55. Silberstein, L. E., L. C. Jefferies, J. Goldman, et al.: Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 78 (1991) 2372-2386
56. Skevakis, L., C. E. Frasch, J. M. Zahradnik, and R. Dolin: Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis. J. Infect. Dis. 149 (1984) 387-396
57. Sutton, A., W. F. Vann, A. B. Karpas, K. E. Stein, and R. Schneerson: An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides. J. Immunol. Methods 82 (1985) 215-224
58. Tilton, R. C., F. Dias, and R. W. Ryan: Comparative evaluation of three commercial products and counterimmunoelectrophoresis for the detection of antigens in cerebrospinal fluid. J. Clin. Microbiol. 20 (1984) 231-234
59. Westerink, M. A., P. C. Giardina, M. A. Apicella, and T. Kieber-Emmons: Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92 (1995) 4021-4025
60. Zollinger, W. D., J. E. Boslego, C. E. Frasch, and L. O. Froholm: Safety of vaccines containing meningococcal group B polysaccharide. Lancet 2 (1984) 166
61. Zollinger, W. D. and R. E. Mandrell: Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide. Infect. Immun. 40 (1983) 257-264
62. Zollinger, W. D., R. E. Mandrell, P. Altieri, S. Berman, J. Lowenthal, and M. S. Artenstein: Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J. Infect. Dis. 137 (1978) 728-739